Betaglycan has multiple binding sites for transforming growth factor-beta 1

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Betaglycan functions as a type III receptor for transforming growth factor-beta (TGF-beta).
• Previous studies have proposed different locations for the TGF-beta binding site within betaglycan's extracellular domain.

Purpose of the Study:

• To investigate the precise location and nature of TGF-beta binding sites within the betaglycan extracellular domain.
• To determine if multiple TGF-beta binding sites exist on betaglycan.

Main Methods:

• Bacterial expression of betaglycan fragments (bg1,2 and bg3).
• Radioligand binding assays using 125I-labeled TGF-beta and betaglycan fragments.
• Bioactivity assays to assess TGF-beta enhancement by betaglycan fragments.
• Competitive binding inhibition assays.

Main Results:

• Both N-terminal (bg1,2) and C-terminal (bg3) fragments of betaglycan competed for TGF-beta binding.
• The N-terminal fragment (bg1,2) exhibited higher affinity for TGF-beta than the C-terminal fragment (bg3).
• Both fragments enhanced TGF-beta bioactivity, with the whole ectodomain being most potent. Binding interactions were mutually inhibitory between fragments and inhibited by decorin proteoglycans.

Conclusions:

• Betaglycan contains at least two distinct binding sites for TGF-beta.
• These binding sites likely recognize the same or overlapping epitopes on TGF-beta.
• The findings clarify the molecular interactions between betaglycan and TGF-beta, impacting receptor function and signaling.